HighVista Strategies »

Newamsterdam Pharma Co Nv shares owned by HighVista Strategies

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $905k 32k 28.44
2025-06-30 $349k 19k 18.11

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Bain Capital Life Sciences Investors
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Viking Global Investors
FMR
Deerfield Management Company
Jennison Associates
Wellington Management Company
Polar Capital Holdings
Medicxi Ventures Management
Adage Capital Partners GP
Cormorant Asset Management
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv